Recent advances in the high throughput screening of compounds for biological activity have given rise to the need for large numbers of compounds by pharmaceutical, biotechnology and other life science companies. These companies routinely acquire and screen thousands of compounds a year in search of novel classes of active compounds.

By coupling Tripos' molecular design technology with its synthesis capabilities, Tripos has brought to market LeadQuest^TM, a growing compound library of greater than 50,000 compounds that meet our diversity and purity criteria. LeadQuest's compounds are based on a general understanding of biological relevance and are suitable for initial screening of any biological test system.

LeadQuest is an efficient source of compounds for screening that eliminates redundant and impure samples from the screening effort. When LeadQuest compounds demonstrate activity in company assays, Tripos can quickly provide hundreds of similar compounds for follow-up screening and lead optimization.